Merck future plans still unclear
Merck Laboratories has announced plans to cut 4,400 jobs worldwide.
So far, Merck has refused to comment on where the jobs cull would impact most, after it failed to realise third-quarter earning estimates.
The company also said that earnings would come in below Q4 estimates, blaming a drop in sales of its arthritic drug Vioxx and a lack of new drugs on the market.
